£790.00

It has never been this cheap. We have no record of a lower price.

£790 today · cheaper than every other day in the last 3 months

World Outlook for Non-Hodgkin Lymphoma 2025-2030 Study

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 84 days · 84 data points (no recent data)

Historical
Generating forecast…
£790.00 £750.50 £766.30 £782.10 £797.90 £813.70 £829.50 11 August 2026 31 August 2026 21 September 2026 12 October 2026 02 November 2026
View at Amazon ↗

Price data checked 7 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 84 days • 1 price levels

Days at Price
84 days 0 21 42 63 84 £790 Days at Price

Price Analysis

Most common price: £790 (84 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 84 days

Description

Gain a comprehensive global perspective on the non-Hodgkin lymphoma market with this detailed study. Covering more than 190 countries, the report provides essential data for understanding market dynamics through 2030. Each year includes estimates for latent demand, also known as potential industry earnings (P.I.E.), measured in millions of U.S. dollars. By utilizing econometric models that project fundamental economic dynamics, this report allows for precise comparisons across different regions and nations. Readers can access the percent share each country holds within its specific region and its total share of the global market. These comparative benchmarks enable users to quickly assess a country's market position relative to others, providing a clear view of the economic landscape for non-Hodgkin lymphoma.

Key Features

Covers the global outlook for non-Hodgkin lymphoma across more than 190 countries.

Provides latent demand estimates, or potential industry earnings (P.I.E.), in millions of U.S. dollars for each reported year.

Includes regional and global percent share data to allow for quick country-to-country comparisons.

Uses econometric models to project fundamental economic dynamics within and across individual countries.

Offers comparative benchmarks to help gauge a country's market position against the rest of the world.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
07 May 2024

Similar Products You Might Like

World Outlook for Non-Hodgkin Lymphoma Treatments 2025-2030
99% match

World Outlook for Non-Hodgkin Lymphoma Treatments 2025-2030

£790.00 06 Nov 2026
The 2023-2028 World Outlook for Non-Hodgkin Lymphoma Treatments
99% match

The 2023-2028 World Outlook for Non-Hodgkin Lymphoma Treatments

Price unavailable
World Outlook 2025-2030: Non-Hodgkin's & Chronic Lymphoma
99% match

World Outlook 2025-2030: Non-Hodgkin's & Chronic Lymphoma

£790.00 07 Nov 2026
The 2023-2028 World Outlook for Non-Hodgkin Lymphoma
99% match

The 2023-2028 World Outlook for Non-Hodgkin Lymphoma

Price unavailable
Non-Hodgkin Lymphoma Outlook 2023-2028 - US Market Study
99% match

Non-Hodgkin Lymphoma Outlook 2023-2028 - US Market Study

£520.00 03 Nov 2026
Non-Hodgkin Lymphoma Outlook in India 2023-2028 Study
99% match

Non-Hodgkin Lymphoma Outlook in India 2023-2028 Study

£515.00 03 Nov 2026
Non-Hodgkin Lymphoma Treatment Outlook 2023-2028 Report
99% match

Non-Hodgkin Lymphoma Treatment Outlook 2023-2028 Report

£520.00 13 Sep 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China
99% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China

£495.00 02 Oct 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan
99% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan

£495.00 25 Aug 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in China
99% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in China

£495.00 03 Nov 2026
Non-Hodgkin's and Chronic Lymphoma Market Outlook in India
99% match

Non-Hodgkin's and Chronic Lymphoma Market Outlook in India

£515.00 08 Nov 2026
Non-Hodgkin's and Chronic Lymphoma Treatment Outlook 2023-2028
99% match

Non-Hodgkin's and Chronic Lymphoma Treatment Outlook 2023-2028

£520.00 03 Nov 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan
99% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan

£495.00 07 Nov 2026
The 2023 Report on Non-Hodgkin Lymphoma Treatments: World Market Segmentation by City
99% match

The 2023 Report on Non-Hodgkin Lymphoma Treatments: World Market Segmentation by City

£795.00 02 Nov 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China
98% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China

£495.00 07 Nov 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan
98% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan

£495.00 06 Nov 2026
The 2021-2026 World Outlook for Non-Hodgkin Lymphoma (NHL) Therapeutics
98% match

The 2021-2026 World Outlook for Non-Hodgkin Lymphoma (NHL) Therapeutics

Price unavailable
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics
98% match

The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics

£790.00 29 Oct 2026
Non-Hodgkin Lymphoma Treatment Outlook 2023-2028 Study
98% match

Non-Hodgkin Lymphoma Treatment Outlook 2023-2028 Study

£490.00 25 Aug 2026
Non-Hodgkin Lymphoma US Zip Code Outlook 2023-2028
98% match

Non-Hodgkin Lymphoma US Zip Code Outlook 2023-2028

£490.00 28 Aug 2026
The 2023-2028 Outlook for Lymphoma Treatments in the United States
98% match

The 2023-2028 Outlook for Lymphoma Treatments in the United States

£520.00 26 Aug 2026
Lymphoma Treatment Outlook in India 2023-2028 Study
98% match

Lymphoma Treatment Outlook in India 2023-2028 Study

£515.00 06 Nov 2026
Non-Hodgkin and Chronic Lymphoma Treatment Outlook 2023-2028
98% match

Non-Hodgkin and Chronic Lymphoma Treatment Outlook 2023-2028

£490.00 28 Aug 2026
Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study
98% match

Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study

£520.00 07 Nov 2026